Serratia marcescens is an opportunistic pathogen that can cause many human infections, including respiratory tract infections, urinary tract infections, wound infections, and bacteremia.
The epidemiology of Serratia marcescens infections is complex, and the bacterium can be found in various environments, including hospitals, nursing homes, and water sources. S. marcescens is an important nosocomial pathogen commonly associated with hospital-acquired infections, particularly in intensive care units (ICUs).
Serratia marcescens is estimated to account for approximately 2-3% of all nosocomial infections in the United States.
marcescens infections have been reported in a group of settings, including hospitals, nursing homes, and long-term care facilities. In a study conducted in a healthcare in Brazil, S. marcescens was the third most isolated gram-negative bacteria from clinical samples.
A surveillance study conducted in a hospital in Greece found that Serratia marcescens accounted for 4.4% of all gram-negative bacteria isolated from clinical specimens.
Outbreaks of S. marcescens infections have been reported in neonatal intensive care units, with attack rates ranging from 14% to 33%.
In addition to healthcare-associated infections, S. marcescens can also cause community-acquired infections, particularly in individuals with weakened immune systems or underlying medical conditions.
Risk factors for Serratia marcescens infections include prolonged hospitalization, invasive medical procedures, mechanical ventilation, and indwelling medical devices like urinary catheters and central venous catheters.
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Serratia
Species: Serratia marcescens
Structure:
Serratia marcescens is a gram-negative, rod-shaped bacterium, typically measuring about 0.5-1.0 micrometers in width and 1.5-3.0 micrometers in length.
Serratia marcescens has an outer membrane that covers the cell wall. The outer membrane contains lipopolysaccharides, contributing to the bacterium’s virulence and ability to resist host defenses.
The cell wall of S. marcescens is composed of peptidoglycan, which provides rigidity and protection to the cell.
The plasma membrane is a phospholipid bilayer surrounding the cell’s cytoplasm. It is responsible for regulating the movement of molecules into and out of the cell.
Peritrichous flagella: S. marcescens is motile, employing peritrichous flagella, which are distributed over the entire surface of the cell. The flagella enable the bacterium to move towards or away from environmental stimuli.
The cytoplasm of S. marcescens contains various proteins, enzymes, and other molecules that are involved in the bacterium’s metabolic and cellular processes.
The nucleoid is a region within the cytoplasm where the bacterium’s genetic material is located. In S. marcescens, the genetic material is organized into a single circular chromosome.
Serratia marcescens can also carry plasmids, which are smaller, circular pieces of DNA that can confer various traits to the bacterium, such as antibiotic resistance or the ability to produce virulence factors.
Prodigiosin pigment: S. marcescens institute a bright red pigment called prodigiosin. This pigment is not essential for bacterial growth or survival, but it can be used as a virulence factor by the bacterium. Prodigiosin has been shown to have antimicrobial properties and can also stimulate inflammation in host cells.
Serratia marcescens has a surface layer called the S-layer, composed of proteins that form a lattice-like structure on the bacterium’s surface. The S-layer can protect against environmental stressors and aid bacterial adhesion and colonization.
The antigens can be used to classify the bacterium into different serotypes. Here are some of the antigenic types of S. marcescens:
Serratia marcescens has a complex lipopolysaccharide (LPS) structure that includes an O-antigen. The O-antigen is a highly variable component of the LPS that can be used to differentiate between different serotypes of the bacterium.
K-antigens:S. marcescens can also produce a capsule composed of a colanic acid polymer. The capsule is a virulence factor that can help the bacterium to evade host defenses. The antigenic determinants of the capsule are called K-antigens, and different serotypes of Serratia marcescens can have different K-antigens.
H-antigens:S. marcescens is motile, utilizing peritrichous flagella composed of a protein named flagellin. The antigenic determinants of flagellin are called H-antigens, and different serotypes of Serratia marcescens can have different H-antigens.
Overview of the pathogenesis of Serratia marcescens:
Adhesion: S. marcescens can adhere to host cells and surfaces using type I fimbriae and the S-layer. Adhesion is an essential step in colonization and infection.
Invasion: Serratia marcescens produces several proteases, including serrapeptase and serralysin, which can degrade host tissues and enable the bacterium to penetrate deeper into the body.
Serratia marcescens produces lipases that can degrade lipids in host tissues, facilitating bacterial invasion and dissemination.
Toxin production: The bacterium can produce hemolysin, which can damage red blood cells and other host cells, and serrawettin W2, which can disrupt cell membranes and cause cell death.
Immune evasion: the bacterium can produce a capsule composed of colanic acid, making it more difficult for host immune cells to phagocytose the bacterium.
Serratia marcescens produces a shiny red pigment called prodigiosin. While not a classical virulence factor, prodigiosin has been shown to have antimicrobial properties and can also stimulate inflammation in host cells.
Serratia marcescens can form biofilms, complex communities of bacteria encased in a protective extracellular matrix. Biofilms can protect the bacteria from antibiotics and host defenses and facilitate the infection’s spread.
Physical barriers: The skin and mucous membranes of the body act as physicalbarriers that prevent the entry of S. marcescens. The respiratory, gastrointestinal, and urinary tracts also have mechanisms to flush out bacteria and prevent colonization.
The innate immune system is the primary defense against bacterial pathogens. It includes components such as phagocytic cells (neutrophils and macrophages) that can engulf and destroy bacteria, as well as complement proteins that can help to identify and eliminate bacteria.
Adaptive immune system: The adaptive immune system produces antibodies and T cells that can specifically recognize and eliminate Serratia marcescens and other bacterial pathogens.
Cytokines are signaling molecules produced by immune cells in response to infection, which activate immune cells and induce inflammation, which can help limit the spread of the infection.
Serratia marcescens can cause a range of clinical manifestations, including community-acquired and healthcare-associated infections.
Healthcare-associated infections: S. marcescens is a common cause of healthcare-associated infections, including bloodstream infections, pneumonia, and urinary tract infections.
Serratia marcescens can cause meningitis, an infection of the membranes margining the brain and spinal cord. It can lead to fever, headache, stiff neck, and other neurological symptoms.
Endocarditis: An infection of the heart valves. It can lead to fever, fatigue, shortness of breath, and other symptoms.
S. marcescens can cause osteomyelitis, an infection of the bone. It can lead to pain, swelling, and reduced mobility in the affected area.
S. marcescens can cause septicemia, a severe bloodstream infection leading to sepsis, shock, and multiple organ failure.
Necrotizing fasciitis: A rare but severe infection that affects the skin, subcutaneous tissues, and fascia, leading to tissue death, organ failure, and even death.
Serological tests may be used to detect antibodies against Serratiamarcescens in the blood, which can indicate a recent or current infection.
Cerebrospinal fluid (CSF) analysis can identify S. marcescens in patients with suspected meningitis.
Nucleic acid amplification tests (NAATs): NAATs, such as PCR or real-time PCR, can amplify and detect the genetic material of S. marcescens in clinical specimens. These tests offer high sensitivity and specificity and can rapidly diagnose Serratia marcescens infections.
Automated blood cultures systems, such as BacT/ALERT or BACTEC, can rapidly detect the growth of Serratia marcescens in blood samples, allowing for prompt diagnosis of bloodstream infections.
MALDI-TOF mass spectrometry is a high-throughput method for identifying bacterial species, including S. marcescens, based on their protein profiles.
Matrix-assisted laser desorption/ionization time-of-flight imaging mass spectrometry (MALDI-TOF IMS): It is a new technique for detecting Serratia marcescens in tissue samples, providing a faster and more accurate diagnosis of infections such as necrotizing fasciitis.
Healthcare workers and visitors must wash their hands periodically with soap and water or use alcohol-based hand sanitizers.
Environmental cleaning, including routine cleaning and disinfection of patient rooms and equipment, is essential to prevent the spread of Serratia marcescens. Particular attention should be paid to high-touch surfaces, such as bed rails, doorknobs, and light switches.
Contact precautions, such as wearing gloves and gowns, should be used when caring for infected patients.
Antibiotic stewardship programs can help prevent the development of antibiotic-resistant strains of S. marcescens. Healthcare facilities should develop and implement guidelines for appropriate antibiotic use, including appropriate duration of treatment and selection of antibiotics based on susceptibility testing.
Serratia marcescens is an opportunistic pathogen that can cause many human infections, including respiratory tract infections, urinary tract infections, wound infections, and bacteremia.
The epidemiology of Serratia marcescens infections is complex, and the bacterium can be found in various environments, including hospitals, nursing homes, and water sources. S. marcescens is an important nosocomial pathogen commonly associated with hospital-acquired infections, particularly in intensive care units (ICUs).
Serratia marcescens is estimated to account for approximately 2-3% of all nosocomial infections in the United States.
marcescens infections have been reported in a group of settings, including hospitals, nursing homes, and long-term care facilities. In a study conducted in a healthcare in Brazil, S. marcescens was the third most isolated gram-negative bacteria from clinical samples.
A surveillance study conducted in a hospital in Greece found that Serratia marcescens accounted for 4.4% of all gram-negative bacteria isolated from clinical specimens.
Outbreaks of S. marcescens infections have been reported in neonatal intensive care units, with attack rates ranging from 14% to 33%.
In addition to healthcare-associated infections, S. marcescens can also cause community-acquired infections, particularly in individuals with weakened immune systems or underlying medical conditions.
Risk factors for Serratia marcescens infections include prolonged hospitalization, invasive medical procedures, mechanical ventilation, and indwelling medical devices like urinary catheters and central venous catheters.
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Serratia
Species: Serratia marcescens
Structure:
Serratia marcescens is a gram-negative, rod-shaped bacterium, typically measuring about 0.5-1.0 micrometers in width and 1.5-3.0 micrometers in length.
Serratia marcescens has an outer membrane that covers the cell wall. The outer membrane contains lipopolysaccharides, contributing to the bacterium’s virulence and ability to resist host defenses.
The cell wall of S. marcescens is composed of peptidoglycan, which provides rigidity and protection to the cell.
The plasma membrane is a phospholipid bilayer surrounding the cell’s cytoplasm. It is responsible for regulating the movement of molecules into and out of the cell.
Peritrichous flagella: S. marcescens is motile, employing peritrichous flagella, which are distributed over the entire surface of the cell. The flagella enable the bacterium to move towards or away from environmental stimuli.
The cytoplasm of S. marcescens contains various proteins, enzymes, and other molecules that are involved in the bacterium’s metabolic and cellular processes.
The nucleoid is a region within the cytoplasm where the bacterium’s genetic material is located. In S. marcescens, the genetic material is organized into a single circular chromosome.
Serratia marcescens can also carry plasmids, which are smaller, circular pieces of DNA that can confer various traits to the bacterium, such as antibiotic resistance or the ability to produce virulence factors.
Prodigiosin pigment: S. marcescens institute a bright red pigment called prodigiosin. This pigment is not essential for bacterial growth or survival, but it can be used as a virulence factor by the bacterium. Prodigiosin has been shown to have antimicrobial properties and can also stimulate inflammation in host cells.
Serratia marcescens has a surface layer called the S-layer, composed of proteins that form a lattice-like structure on the bacterium’s surface. The S-layer can protect against environmental stressors and aid bacterial adhesion and colonization.
The antigens can be used to classify the bacterium into different serotypes. Here are some of the antigenic types of S. marcescens:
Serratia marcescens has a complex lipopolysaccharide (LPS) structure that includes an O-antigen. The O-antigen is a highly variable component of the LPS that can be used to differentiate between different serotypes of the bacterium.
K-antigens:S. marcescens can also produce a capsule composed of a colanic acid polymer. The capsule is a virulence factor that can help the bacterium to evade host defenses. The antigenic determinants of the capsule are called K-antigens, and different serotypes of Serratia marcescens can have different K-antigens.
H-antigens:S. marcescens is motile, utilizing peritrichous flagella composed of a protein named flagellin. The antigenic determinants of flagellin are called H-antigens, and different serotypes of Serratia marcescens can have different H-antigens.
Overview of the pathogenesis of Serratia marcescens:
Adhesion: S. marcescens can adhere to host cells and surfaces using type I fimbriae and the S-layer. Adhesion is an essential step in colonization and infection.
Invasion: Serratia marcescens produces several proteases, including serrapeptase and serralysin, which can degrade host tissues and enable the bacterium to penetrate deeper into the body.
Serratia marcescens produces lipases that can degrade lipids in host tissues, facilitating bacterial invasion and dissemination.
Toxin production: The bacterium can produce hemolysin, which can damage red blood cells and other host cells, and serrawettin W2, which can disrupt cell membranes and cause cell death.
Immune evasion: the bacterium can produce a capsule composed of colanic acid, making it more difficult for host immune cells to phagocytose the bacterium.
Serratia marcescens produces a shiny red pigment called prodigiosin. While not a classical virulence factor, prodigiosin has been shown to have antimicrobial properties and can also stimulate inflammation in host cells.
Serratia marcescens can form biofilms, complex communities of bacteria encased in a protective extracellular matrix. Biofilms can protect the bacteria from antibiotics and host defenses and facilitate the infection’s spread.
Physical barriers: The skin and mucous membranes of the body act as physicalbarriers that prevent the entry of S. marcescens. The respiratory, gastrointestinal, and urinary tracts also have mechanisms to flush out bacteria and prevent colonization.
The innate immune system is the primary defense against bacterial pathogens. It includes components such as phagocytic cells (neutrophils and macrophages) that can engulf and destroy bacteria, as well as complement proteins that can help to identify and eliminate bacteria.
Adaptive immune system: The adaptive immune system produces antibodies and T cells that can specifically recognize and eliminate Serratia marcescens and other bacterial pathogens.
Cytokines are signaling molecules produced by immune cells in response to infection, which activate immune cells and induce inflammation, which can help limit the spread of the infection.
Serratia marcescens can cause a range of clinical manifestations, including community-acquired and healthcare-associated infections.
Healthcare-associated infections: S. marcescens is a common cause of healthcare-associated infections, including bloodstream infections, pneumonia, and urinary tract infections.
Serratia marcescens can cause meningitis, an infection of the membranes margining the brain and spinal cord. It can lead to fever, headache, stiff neck, and other neurological symptoms.
Endocarditis: An infection of the heart valves. It can lead to fever, fatigue, shortness of breath, and other symptoms.
S. marcescens can cause osteomyelitis, an infection of the bone. It can lead to pain, swelling, and reduced mobility in the affected area.
S. marcescens can cause septicemia, a severe bloodstream infection leading to sepsis, shock, and multiple organ failure.
Necrotizing fasciitis: A rare but severe infection that affects the skin, subcutaneous tissues, and fascia, leading to tissue death, organ failure, and even death.
Serological tests may be used to detect antibodies against Serratiamarcescens in the blood, which can indicate a recent or current infection.
Cerebrospinal fluid (CSF) analysis can identify S. marcescens in patients with suspected meningitis.
Nucleic acid amplification tests (NAATs): NAATs, such as PCR or real-time PCR, can amplify and detect the genetic material of S. marcescens in clinical specimens. These tests offer high sensitivity and specificity and can rapidly diagnose Serratia marcescens infections.
Automated blood cultures systems, such as BacT/ALERT or BACTEC, can rapidly detect the growth of Serratia marcescens in blood samples, allowing for prompt diagnosis of bloodstream infections.
MALDI-TOF mass spectrometry is a high-throughput method for identifying bacterial species, including S. marcescens, based on their protein profiles.
Matrix-assisted laser desorption/ionization time-of-flight imaging mass spectrometry (MALDI-TOF IMS): It is a new technique for detecting Serratia marcescens in tissue samples, providing a faster and more accurate diagnosis of infections such as necrotizing fasciitis.
Healthcare workers and visitors must wash their hands periodically with soap and water or use alcohol-based hand sanitizers.
Environmental cleaning, including routine cleaning and disinfection of patient rooms and equipment, is essential to prevent the spread of Serratia marcescens. Particular attention should be paid to high-touch surfaces, such as bed rails, doorknobs, and light switches.
Contact precautions, such as wearing gloves and gowns, should be used when caring for infected patients.
Antibiotic stewardship programs can help prevent the development of antibiotic-resistant strains of S. marcescens. Healthcare facilities should develop and implement guidelines for appropriate antibiotic use, including appropriate duration of treatment and selection of antibiotics based on susceptibility testing.
Serratia marcescens is an opportunistic pathogen that can cause many human infections, including respiratory tract infections, urinary tract infections, wound infections, and bacteremia.
The epidemiology of Serratia marcescens infections is complex, and the bacterium can be found in various environments, including hospitals, nursing homes, and water sources. S. marcescens is an important nosocomial pathogen commonly associated with hospital-acquired infections, particularly in intensive care units (ICUs).
Serratia marcescens is estimated to account for approximately 2-3% of all nosocomial infections in the United States.
marcescens infections have been reported in a group of settings, including hospitals, nursing homes, and long-term care facilities. In a study conducted in a healthcare in Brazil, S. marcescens was the third most isolated gram-negative bacteria from clinical samples.
A surveillance study conducted in a hospital in Greece found that Serratia marcescens accounted for 4.4% of all gram-negative bacteria isolated from clinical specimens.
Outbreaks of S. marcescens infections have been reported in neonatal intensive care units, with attack rates ranging from 14% to 33%.
In addition to healthcare-associated infections, S. marcescens can also cause community-acquired infections, particularly in individuals with weakened immune systems or underlying medical conditions.
Risk factors for Serratia marcescens infections include prolonged hospitalization, invasive medical procedures, mechanical ventilation, and indwelling medical devices like urinary catheters and central venous catheters.
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Serratia
Species: Serratia marcescens
Structure:
Serratia marcescens is a gram-negative, rod-shaped bacterium, typically measuring about 0.5-1.0 micrometers in width and 1.5-3.0 micrometers in length.
Serratia marcescens has an outer membrane that covers the cell wall. The outer membrane contains lipopolysaccharides, contributing to the bacterium’s virulence and ability to resist host defenses.
The cell wall of S. marcescens is composed of peptidoglycan, which provides rigidity and protection to the cell.
The plasma membrane is a phospholipid bilayer surrounding the cell’s cytoplasm. It is responsible for regulating the movement of molecules into and out of the cell.
Peritrichous flagella: S. marcescens is motile, employing peritrichous flagella, which are distributed over the entire surface of the cell. The flagella enable the bacterium to move towards or away from environmental stimuli.
The cytoplasm of S. marcescens contains various proteins, enzymes, and other molecules that are involved in the bacterium’s metabolic and cellular processes.
The nucleoid is a region within the cytoplasm where the bacterium’s genetic material is located. In S. marcescens, the genetic material is organized into a single circular chromosome.
Serratia marcescens can also carry plasmids, which are smaller, circular pieces of DNA that can confer various traits to the bacterium, such as antibiotic resistance or the ability to produce virulence factors.
Prodigiosin pigment: S. marcescens institute a bright red pigment called prodigiosin. This pigment is not essential for bacterial growth or survival, but it can be used as a virulence factor by the bacterium. Prodigiosin has been shown to have antimicrobial properties and can also stimulate inflammation in host cells.
Serratia marcescens has a surface layer called the S-layer, composed of proteins that form a lattice-like structure on the bacterium’s surface. The S-layer can protect against environmental stressors and aid bacterial adhesion and colonization.
The antigens can be used to classify the bacterium into different serotypes. Here are some of the antigenic types of S. marcescens:
Serratia marcescens has a complex lipopolysaccharide (LPS) structure that includes an O-antigen. The O-antigen is a highly variable component of the LPS that can be used to differentiate between different serotypes of the bacterium.
K-antigens:S. marcescens can also produce a capsule composed of a colanic acid polymer. The capsule is a virulence factor that can help the bacterium to evade host defenses. The antigenic determinants of the capsule are called K-antigens, and different serotypes of Serratia marcescens can have different K-antigens.
H-antigens:S. marcescens is motile, utilizing peritrichous flagella composed of a protein named flagellin. The antigenic determinants of flagellin are called H-antigens, and different serotypes of Serratia marcescens can have different H-antigens.
Overview of the pathogenesis of Serratia marcescens:
Adhesion: S. marcescens can adhere to host cells and surfaces using type I fimbriae and the S-layer. Adhesion is an essential step in colonization and infection.
Invasion: Serratia marcescens produces several proteases, including serrapeptase and serralysin, which can degrade host tissues and enable the bacterium to penetrate deeper into the body.
Serratia marcescens produces lipases that can degrade lipids in host tissues, facilitating bacterial invasion and dissemination.
Toxin production: The bacterium can produce hemolysin, which can damage red blood cells and other host cells, and serrawettin W2, which can disrupt cell membranes and cause cell death.
Immune evasion: the bacterium can produce a capsule composed of colanic acid, making it more difficult for host immune cells to phagocytose the bacterium.
Serratia marcescens produces a shiny red pigment called prodigiosin. While not a classical virulence factor, prodigiosin has been shown to have antimicrobial properties and can also stimulate inflammation in host cells.
Serratia marcescens can form biofilms, complex communities of bacteria encased in a protective extracellular matrix. Biofilms can protect the bacteria from antibiotics and host defenses and facilitate the infection’s spread.
Physical barriers: The skin and mucous membranes of the body act as physicalbarriers that prevent the entry of S. marcescens. The respiratory, gastrointestinal, and urinary tracts also have mechanisms to flush out bacteria and prevent colonization.
The innate immune system is the primary defense against bacterial pathogens. It includes components such as phagocytic cells (neutrophils and macrophages) that can engulf and destroy bacteria, as well as complement proteins that can help to identify and eliminate bacteria.
Adaptive immune system: The adaptive immune system produces antibodies and T cells that can specifically recognize and eliminate Serratia marcescens and other bacterial pathogens.
Cytokines are signaling molecules produced by immune cells in response to infection, which activate immune cells and induce inflammation, which can help limit the spread of the infection.
Serratia marcescens can cause a range of clinical manifestations, including community-acquired and healthcare-associated infections.
Healthcare-associated infections: S. marcescens is a common cause of healthcare-associated infections, including bloodstream infections, pneumonia, and urinary tract infections.
Serratia marcescens can cause meningitis, an infection of the membranes margining the brain and spinal cord. It can lead to fever, headache, stiff neck, and other neurological symptoms.
Endocarditis: An infection of the heart valves. It can lead to fever, fatigue, shortness of breath, and other symptoms.
S. marcescens can cause osteomyelitis, an infection of the bone. It can lead to pain, swelling, and reduced mobility in the affected area.
S. marcescens can cause septicemia, a severe bloodstream infection leading to sepsis, shock, and multiple organ failure.
Necrotizing fasciitis: A rare but severe infection that affects the skin, subcutaneous tissues, and fascia, leading to tissue death, organ failure, and even death.
Serological tests may be used to detect antibodies against Serratiamarcescens in the blood, which can indicate a recent or current infection.
Cerebrospinal fluid (CSF) analysis can identify S. marcescens in patients with suspected meningitis.
Nucleic acid amplification tests (NAATs): NAATs, such as PCR or real-time PCR, can amplify and detect the genetic material of S. marcescens in clinical specimens. These tests offer high sensitivity and specificity and can rapidly diagnose Serratia marcescens infections.
Automated blood cultures systems, such as BacT/ALERT or BACTEC, can rapidly detect the growth of Serratia marcescens in blood samples, allowing for prompt diagnosis of bloodstream infections.
MALDI-TOF mass spectrometry is a high-throughput method for identifying bacterial species, including S. marcescens, based on their protein profiles.
Matrix-assisted laser desorption/ionization time-of-flight imaging mass spectrometry (MALDI-TOF IMS): It is a new technique for detecting Serratia marcescens in tissue samples, providing a faster and more accurate diagnosis of infections such as necrotizing fasciitis.
Healthcare workers and visitors must wash their hands periodically with soap and water or use alcohol-based hand sanitizers.
Environmental cleaning, including routine cleaning and disinfection of patient rooms and equipment, is essential to prevent the spread of Serratia marcescens. Particular attention should be paid to high-touch surfaces, such as bed rails, doorknobs, and light switches.
Contact precautions, such as wearing gloves and gowns, should be used when caring for infected patients.
Antibiotic stewardship programs can help prevent the development of antibiotic-resistant strains of S. marcescens. Healthcare facilities should develop and implement guidelines for appropriate antibiotic use, including appropriate duration of treatment and selection of antibiotics based on susceptibility testing.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
